Connect with us

Emerging Markets

Luokung Technolgy Corp and FingerMotion 2 Big Data Plays Immune from Didi Global’s (NASDAQ: DIDI) Chinese Contagion

Published

2 years ago

on

didi Global big Data

Government crackdowns in China have had a big negative spillover effect on many Chinese stocks.  DiDi Global (NASDAQ: DIDI) has been acting as a proxy for the rest of the Chinese stocks.  Chinese stocks listed in the U.S. are getting pummeled on security and data-privacy concerns.  Big Data and Chinese stock went into a tailspin after the Cyberspace Administration of China took down Didi’s main app on Independence Day “pending a cybersecurity review.”  The timing of the takedown was one week after its IPO debut and just happened to be on July 4th.  It doesn’t take a detective to figure out politics was in play.  The focus of this article is on 2 Chinese Big Data stocks that are immune from this regulatory risk and were brought down without any thought to the fundamentals.  The key test of Chinese data immunity lies in who owns the data versus who processes the data.  Eventually stocks will decouple and the ones with the strongest fundamentals will rise again.  

Luokung Technology – Leader in Mapping Technology

Luokung Technology (LKCO) is known for its “spatial-temporal big data ” which is really the study of objects or in this case vehicles moving around the city.  Their data is primarily used by ride hailing services.  This means they need to account for vehicle movements, traffic around the vehicle, obstacles, and the movement of people during the planned pickup. The company has also developed a smart city concept that ties traffic, emergency services, delivery, mass transit, and even road repairs into one map that seeks to optimize the movement within the city factoring different priorities like emergency services when they are needed.  A future facet of their business is autonomous driving which will have to factor in not only other vehicles, but pedestrian movements.  If all vehicles have a common interface and are interconnected there can be a general awareness between vehicles allowing everyone to stay safe.  The most difficult part of determining a universal map that consists of cars and pedestrians is connecting to the Internet of Things (IoT) to assist in confirming and predicting pedestrian movement.  The universal driver behind each of their business segments is big data.    

Investor Presentation – BigData Hub Concept

Many data feeds from their digital partners who own and store the data feed into a centralized server where they are dissected, interpreted, and prioritized.  From these data feeds they are able to render a multilayer dimensional map (see below). From this map they are able to generate predictive algorithms capable of figuring the optimal route factoring in traffic.

In essence the company provides DaaS (Data as a Service), SaaS (Software as a Service), PaaS (Platform as a Service), and combinations in between.  Saleya Holdings (eMapgo) which was purchased for $120 million on August 28, 2019 has 3 main revenue stream classifications.  They have map data services, autonomous driving map data services, and in-dash navigation.  

The revenues of the subsidiary are modest at the moment, but represent an enormous emerging market and almost a pure play on the autonomous driving market segment.

The mobile application known as Luokung is primarily a Business to Customer (B2C) situation that utilizes railroad-WiFi in concert with its software apps to provide tailored content that contains relevant information, entertainment, travel, and e-commerce to the long distance rail rider.  The guiding principle behind the service that has over 51 million users is to reduce boredom on the trains and push the idea of discovering new things to do upon arrival.  Advertising is a key component of their model that includes online to offline (O2O) which hopes to engage passengers while enroute, to purchase or do something once they arrive at their destination.  Recommendations are based on users interests which include restaurants, entertainment, accommodations, local snacks, local products, scenic spots, or points of historical significance.  

The Grecent deal with Tencent Holdings (OTCMKTS: TECHY) initially expanded the base of passengers and increased revenue per customer because high-speed rail customers typically spend more.  This eventually morphed into Luokung Location-based Services (LBS) Data Marketing Platform that is a combination of advertising and very detailed maps, points of interest, 20,000 commercial buildings, train stations, shopping malls, and airports.     

They also have Business to Business (B2B) and Business to Government (B2G) services.  These programs operate in real time allowing the business customers like ride hailing services to predict pickup and drop off points and arrival and departure times with greater accuracy. Smart cities seek to control the port of entry, traffic monitoring, and logistical movement using proprietary systems covered by patents and copyrights that allow for the transmission and rendering of extremely detailed maps that are graphically optimized to operated in a low bandwidth infrastructure while bringing the equivalency of terabytes of data.  

Financial Performance

The company has high R&D expenses and high marketing expenses because they operate in a state of continuous improvement in order to keep customers satisfied and retained on their platforms.  The focus of their efforts are on additional features and performance enhancements while at the same time expanding markets and acquiring business or technology that fits. Notes 4&5 in the cost of revenues was primarily intercompany receivables and amortization of intangible assets which serve to only weaken the earnings outlook only in the short run.  .    

LKCO currently has a market capitalization of $515 million and has 318 million shares outstanding.  The company made 3 offerings in 2021 and brought in about $120 million in cash.  They also completed the acquisition of Saleya on March 17, 2021 for $102 million in cash.  They also have strong backing from Geely, a large Chinese car manufacturer and other notable entities and wide industry connections not to mention their cooperation deals with Beidou positioning, Dell, and National Goepspatial.  

Busy Start / Future Catalysts

March: LKCO announced the acquisition of 100% equity interest in EMG, the first-class mapping company. Following the Company’s successful financing of US$120 million, LKCO has completed the acquisition, which has become a wholly owned subsidiary of the Company.

April: The company received a notification letter from Nasdaq stating that it has regained compliance with the requirement rule of minimum bid price in 5550(a)(2).

May: LKCO obtained the contract which is about the new traffic control system and Intelligent Road.
July: It announced a formal strategic cooperation agreement with the National Geospatial Information Center (NGIC) in a range of sectors including geospatial information services. Besides, recently LKCO revealed that it will cooperate with one of the top China’s automakers collecting and managing the data of autonomous driving vehicles.

The stage is set for more acquisitions around the core mapping technology.  They are also winning more contracts in government and with car manufacturers which will boost the financial outlook and perhaps generate the cash they need for more acquisitions.  Processed data is what they sell and it’s quite valuable but the raw data is not something they own.  This is why they are immune to government crackdowns.  The drop in stock price was completely unrelated to government regulation and people will eventually understand that these autonomous cars will need virtual drivers and when they do only a few players in the world like LKCO will be able to take the wheel.  

FingerMotion – Leading InsureTech Player

FNGR has 3 primary business silos.  They have a mobile data and recharge platform, an SMS and MMS payment solutions, and their big data solutions wrapped up in their subsidiary called Sapientus.  These silos are all interconnected because FNGR has direct access to the mobile carriers.  This gives them an unprecedented number of users that can be converted into buying goods and services that FingerMotion is reselling. This availability of user metadata helps them create extremely accurate algorithms that can better predict user behavior in its Big Data arm.


Top Up & Mobile Recharge

The company started in the Top up and mobile recharge business.  In the United States most cell phones are on monthly plans that are paid after usage, but in China the phones add minutes or data in incremental amounts.  FingerMotion has the wholesale license to sell Top up minutes from China Mobile and China Unicom which are the largest telecoms in China, to e-commerce platforms that include AliBaba (NASDAQ: BABA), PingDuoDuo (NASDAQ: PDD), and JD.com (NYSE: JD). These e-commerce platforms have well over a billion users and allow FNGR to market Top up minutes to their respective user bases.  FNGR gets a small sliver of millions of transactions daily.  Their margins are quite thin, but they have no marketing expenses and don’t have to spend money to retain customers like the e-commerce platforms do.  

SMS & MMS

The SMS and MMS business are responsible for most of the gross profit and has been one of the fastest growing business silos in the company.  

 

Big Data

The Big Data business is held in the subsidiary Sapientus.  It is run by a team of seasoned actuaries and data scientists with a specialty in creating algorithms. The life blood of the insurance industry comes down to risk analysis.  The developing insuretec business at Sapientus is driving innovation in the insurance business that enables the real time assessment of an individual based on risk scoring.  They currently have big data agreements with Pacific Life Re and Happy Life Insurance with many more on the way.  

The algorithms developed by their big data research team take many personal factors into account.  However, the data that goes into these algorithms is from non-identifiable people whose information resides on the host server where the data was sourced from.  Think of it as taking a personal profile and instantly type casting them so that they fit into many different molds like a fitness fanatic or a video gamer.  

Their personal identity is lost but their behaviors and what they typically do are turned into an algorithm that uses distributional statistics and cluster variables that would mimic their actual behavior. Insurance risk algorithms would assign risk scores to these behavioral profiles so when queried in real time, that particular individual would be matched against a behavioral profile that was already assigned a risk score and can be immediately quoted.  

The behavioral analytics also have far reaching consequences inside and outside the insurance business.  For example, another application within the field of insurance is fraud detection to ensure the claims match up to the risk profile.  Outside the insurance sector, big data can profile people seeking credit or financial services which represent a huge untapped market due to the unavailability of credit scores in China.  Morphing into the largest credit scoring reporter in China means FNGR could eventually challenge Visa (NYSE: V) or MasterCard (NYSE: MA), American Express (NYSE: AXP) or PayPal (NASDAQ: PYPL) and become a ripe acquisition target for one of these behemoths.  

In fact FNGR should be able to do anything big data provider Snowflake (NASDAQ: SNOW) can do because SNOW is focused behavior around product sales of merchandise while FNGR is more focused on the consumer who is infinitely more complicated.  FNGR uses practically the same structure as SNOW just liess the centralized storage of data. If SNOW was looking toward international expansion FNGR would be on the short list.  When considering the $78 billion market cap of SNOW versus the $120 million FNGR, FNGR might not last even a year on the NASDAQ before they get gobbled up for their unparalleled access to all of China.  

Heavily Shorting the Macro Without Paying Attention to Core Fundamentals

Both stocks FingerMotion and Luokung Technology have active shorts.  The shorts expect continued sector weakness and they have literally done no due diligence on these names.  LKCO has had its short interest rise from 69K to 8.7 million shares in just the past 6 months.  Average daily volume has exploded to 16.5 million.  The short volume is much harder to see in FNGR because it’s traded in the OTC market.  There are 4.2 million shares held at DTC and only 750,000 shares are held by retail as evidenced by the average volume of 20,000 shares traded daily.  That’s only 3% turnover of the real float daily.  The smoking gun signature of the short presence in FNGR are large orders that have been pummeling the bid in quick succession.  

Investment Summary

The market is playing the guilt by association game when it comes to Chinese big data plays.  Any Chinese company that collects, stores, or owns personal data seems to be a target.  Since Chinese companies are not really that well covered or known for their transparency, shorts are pounding on names hoping to play on investors fears that they don’t understand the fundamentals of the business.  This has created an enormous opportunity in a couple of e-commerce and big data plays growing extremely quickly and quietly in China.  Most notably are LKCO and FNGR.  Both of these companies are provided with Big Data and then analyze and manipulate into something that is actionable by the user.  They DON’T OWN THE DATA so they are immune from government intervention.  

Whether it’s finding out where your pickup location is scheduled or an optimized quote on car insurance, Big Data is transforming the lives of the Chinese people.  The Chinese market is enormous so creating disruptive technologies like autonomous drivers or insuretech solutions will catch on and scale very rapidly.  LKCO has invested a tremendous amount into R&D and is on the cusp of monetizing their disruptive solutions to the market.  FNGR is on the verge of rolling out insurtech products that could ultimately transform the Chinese insurance industry and its unthinkable that this name is only worth $120 million when it could completely dominate the insurance market in the coming 2 years.  They are also moving forward with a NASDAQ uplisting that could provide institutional interest that has been lacking while squeezing to shorts to cover their naked positions ahead of the uplisting.        

Disclosure: we hold no position in LKCO or FNGR either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Strong Financials and Social Media Buzz Propel Forza X1, Inc. (NASDAQ:FRZA) to New Heights

Published

2 days ago

on

June 6, 2023

By

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023.

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023. This surge was accompanied by an unprecedented level of trading volume, marking a significant departure from the previously observed average. Notably, the stock’s trading volume had been relatively low in recent months, with numerous days experiencing trading activity of less than 1,000 shares. Without any apparent news or filings, the cause behind this sudden surge remains a subject of intrigue and speculation among market participants.

What happened?

Firstly it’s important to note that $FRZA is a spin-off of Twin Vee PowerCats Co. (Nasdaq: VEEE). $VEEE is the parent company handling the design, manufacturing, and distribution of recreational and commercial, off-shore power catamaran boats while $FRZA is the new developer of electric sport boats with a mission to accelerate the adoption of sustainable recreational boating.

To Discover the Inside Scoop on FRZA, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Upon examination of the company, no discernible filings or press releases have been identified to account for today’s remarkable shift. However, it seems that a tweet disseminated by the company caught the attention of retail investors, subsequently generating an enormous surge in trading volume.

This recent occurrence serves as yet another compelling demonstration of the significant impact that the retail community can exert when armed with information regarding a small float micro-cap stock, particularly when the conditions align favorably and validate the potential for substantial gains. The tweet, skillfully crafted by the company’s social media team, featured a compelling GIF and clever “Don’t miss the boat” blurb, demonstrating a keen understanding of their business’s essence. 

The timely and engaging content proved to be a perfect execution, capturing the attention and imagination of investors in a manner that resonated deeply with the nature of the company’s operations.

Overview of Twin Vee PowerCats Co. Financials

Could the surge in share price also reflect the market’s enthusiastic response to Twin Vee’s strong financial results for the first quarter of 2023? 

On May 15, 2023, Twin Vee PowerCats Co. released its financials demonstrating a substantial increase in net revenue and notable improvements in the gas-powered boat segment.

https://twitter.com/JohnZidar/status/1665685698400141313?s=20

Twin Vee PowerCats Co. (Nasdaq: VEEE) reported strong financial results for the first quarter ended March 31, 2023. The company experienced a notable 51% increase in net revenue, reaching $8.9 million compared to $5.9 million in the same period last year. The gas-powered boat segment achieved a net income of $181,000, significantly improving from the net loss of $626,000 in Q1 2022.

However, as per GAAP accounting policy, Twin Vee’s consolidated financial statements resulted in a total net loss of $1.8 million for the quarter, primarily due to their majority ownership in Forza X1, Inc. (Nasdaq: FRZA), an electric boat company. Twin Vee reported cash, cash equivalents, restricted cash, and marketable securities of approximately $12.6 million as of March 31, 2023.

The company has been expanding its product lineup, including introducing the Aquasport mono-hull boat brand. Twin Vee is confident these efforts will contribute to business scalability and brand growth. They aim to optimize inventory levels and production costs while closely monitoring market conditions, dealer inventories, and economic indicators.

Financial highlights for Q1 2023

  • Total revenue: $8,877,000 (51% increase compared to Q1 2022)
  • Gross profit: $3,222,000
  • Net income from gas-powered boats segment: $182,000
  • Net loss from Forza X1 (electric boat entity): $2,005,000
  • Loss from Fix My Boat (franchise business): $5,000
  • Adjusted net loss (excluding non-cash charges): $1,347,000
  • Adjusted net income from gas-powered boats segment: $265,000

Twin Vee’s consolidated cash, cash equivalents, restricted cash, and marketable securities were $23,457,000 as of March 31, 2023. Forza X1 reported $10,683,000 in the same category, while Twin Vee’s core business had $12,643,000, and Fix My Boat had approximately $132,000.

We will closely monitor the performance of Forza X1, Inc. (Nasdaq: FRZA) in the coming weeks, considering that it is a spinoff from its parent company. It is crucial to conduct thorough research, particularly for companies like FRZA that have yet to achieve profitability. However, it is worth noting that the parent company has been making notable progress, as evidenced by its recent financial results, which revealed a substantial increase in the bottom line.

We will update you on FRZA when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Sasin Tipchai from Pixabay

Continue Reading

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

1 week ago

on

May 31, 2023

By

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

3 weeks ago

on

May 21, 2023

By

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.